ORPHAZYME A/S

ORPHA
Real-time Estimate Quote. Real-time Estimate  - 10/18 09:55:27 am
26.49DKK -5.93%

Turn to zoom
Prev.28.1600
Open28.4000
High28.4000
Low26.8000
Volume146 786
Latest news
3d ago
10/08
10/07
10/07
Chart ORPHAZYME A/S
Technical analysis trends
Short TermMid-TermLong Term
TrendBearishBearishBearish
Resistance28,249,544,8
Spread/Res.-4,8%-46%-40%
Spread/Supp.6,8%6,8%6,8%
Support25,225,225,2
Financials
Sales 2021 24,4 M 3,80 M 3,80 M
Net income 2021 -634 M -98,8 M -98,8 M
Net cash 2021 122 M 19,0 M 19,0 M
P/E ratio 2021 -1,83x
Yield 2021 -
Capitalization 984 M 153 M 153 M
EV / Sales 2021 35,4x
EV / Sales 2022 30,7x
Nbr of Employees 180
Free-Float 98,6%
Company
Orphazyme A/S, formerly Orphazyme ApS, is a Denmark-based company active within the biopharmaceutical industry. It develops new therapies for the treatment of a family of genetic disorders. The Company's main focus is on preclinical development of medicines for the treatment of lysosomal storage...

>> Read more
Sector :
Bio Therapeutic Drugs
Calendar :
2022-03-04 Earnings Release
Trading Rating :
Investor Rating : -

Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 2
Last Close Price 28,16 DKK
Average target price 60,50 DKK
Spread / Average Target 115%